Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All consented cases of age more than 18 years who are to have their first prostatic biopsy owing to clinical or biochemical suspicion of carcinoma prostate
Exclusion criteria
Exclusion criteria: a. History of active anal disease, anal fissures, haemorrhoids, rectal ulcers b. Chronic pelvic pain syndrome c. Active urinary tract infections d. Coagulopathies e. Neuropathies f. Uncontrolled diabetes g. Ingestion of aspirin or clopidogrel or any other antiplatelet drugs h. Recent use of narcotics and analgesics i. Known allergy to diltiazem or lignocaine j. Low systolic blood pressure ( k. Aggravated CHF, chronic kidney disease and chronic liver disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the pain score of patients experiencing periprocedural pain in those receiving a combination of topical diltiazem gel, diclofenac suppository and periprostatic nerve block vs periprostatic nerve block for transrectal ultrasonography-guided biopsy of the prostate (Assessed by using standard ten-point visual analogue scale)Timepoint: At the time of procedure and at the end of procedure | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare periprocedural bleeding per rectum between 2 groupsTimepoint: Until post procedure day 1;To compare post procedural urinary tract infection between 2 groupsTimepoint: Until post procedure day 7;To compare the effect of administration of a combination of topical diltiazem gel, diclofenac suppository & periprostatic nerve block vs periprostatic nerve block alone on duration of procedureTimepoint: compare total duration of procedure | — |
Countries
India
Contacts
All India Institute of Medical Sciences, Bhubaneswar